Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
MK5475-007: A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study To Evaluate The Efficacy And Safety Of MK-5475 In Adults With Pulmonary Arterial Hypertension
Booth, David
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/21/21
→
1/29/25
Funding
Merck Sharp & Dohme Corporation:
$80,022.00
View all
View less